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CHAPTER I
GENERAL INTRODUCTION
Kansas is among the Nation's leaders in feedlot cattle. Kansas ranked
third with 4,155,000 head of fed cattle marketed from over 1900 feedlots in 1988.
The number of cattle on feed has increased substantially over the last decade. In
1974, there were 1,160,000 head on feed compared to 1,535,000 head as of
February, 1989 (USDA, 1989). Cattle feeding today is viewed as a business
opportunity that is heavily dictated by consumer demands. Marketing research
indicates a consumer preference toward leaner beef. If demand increases for
leaner finished cattle, feedlots will feed younger cattle and should be able to
market cattle at an earlier stage of growth with less fat deposit. However, there
is a marketing dilemma due to traditional carcass price discounts of $.22 to
.33/kg for the leaner Select as compared to Choice quality cattle (Eng, 1986).
Nonetheless, if a leaner beef product will improve consumer beef demand, the
beef industry should prosper from a production cost and efficiency standpoint.
For more than 30 years, one of the greatest opportunities to capitalize on
improved efficiency resulting from leaner beef production has been recognizing
the important role of growth promoting hormones. Estrogens are the major
hormonal compounds used as growth promotants in the production of beef in
the U.S. (Preston, 1975). In early studies, Dinusson et al. (1948) reported that
implanting heifers with Diethylstilbestrol (DES), a compound with estrogenic
activity, resulted in increases of 12 to 16% in daily gains. Burroughs et al.
(1954) first discussed the oral effectiveness of DES in stimulating gains of
growing-finishing cattle. As of November, 1979, the use of DES by cattle
producers was officially banned for reasons unrelated to its use as a growth
promotant in cattle (Preston, 1987). In more recent years, numerous research
studies have indicated that growth promotants (estrogens) increase rate of gain
and feed efficiency of steers and heifers (Preston, 1975). In addition to the
conventional implants that contain estrogen or estrogen-like compounds, an
androgenic compound called trenbolone acetate (TBA) has been approved
recently by the FDA. It is a synthetic testosterone analogue that is approximately
10-50 times more anabolically active than testosterone itself (Neumann, 1976).
This product, when combined with estrogenic compounds in bulls, steers, and
heifers has resulted in improved average daily gain and feed efficiency
(Grandadam et al., 1975; Galbraith, 1982; Fabry et al., 1983; Brethour, 1986).
Heitzman (1976) suggested that androgens and estrogens are both necessary to
realize maximum growth potential. Therefore, the objectives of these studies
were to determine the effects of trenbolone acetate in combination with
estrogenic implants on performance and carcass characteristics of steers and
heifers.
CHAPTER n
GENERAL REVIEW OF LITERATURE
Endocrine Relationships to Growth
Gonadal Hormones. Extensive research has been conducted to delineate
the endocrine relationships necessary for optimum growth in domestic livestock.
There are many growth promoting compounds of both endogenous and exogenous
origin that affect growth and development of beef cattle. These growth promoting
compounds can be manipulated to enhance either the rate, extent, or efficiency of
animal growth, which is critical to the future of the livestock industry. Gonadal
hormones can be divided into androgenic and estrogenic steroid hormone
classification.
Androgens. In the male, androgens in the form of testosterone are produced
by the Leydig cells of the testes, with a limited amount produced by the adrenal
cortex. Androgens are involved in the stimulation of spermatogenesis, development
and secretion of accessory sex organs, maintenance of secondary sex characteristics,
production of anabolic effects and induction of aggressive behavior (Reeves, 1987).
Intact bulls have a higher rate of gain than steers due to the presence of
higher concentrations of endogenous male hormones (Galbraith et al., 1978; Fisher
et al., 1986b). It is thought that endogenous testosterone acts directly on skeletal
muscle by increasing the rate of protein synthesis and deposition (Trenkle, 1987).
Schanbacher et al. (1980) concluded that testosterone is associated with a positive
nitrogen balance, increased carcass protein, and decreased fat production. While
castration has been practiced to provide a higher quality carcass for marketing, it
has caused a reduction in live weight gain and lean tissue within the carcass.
Compared to bulls, steers generally result in higher quality grade, finish, and
tenderness characteristics in meat carcasses. Castration also minimizes management
problems usually associated with intact males (Unruh, 1986). Interest in androgen
treatment of heifers and the recent availability of trenbolone acetate, a synthetic
testosterone implant, has resulted in reports of significant improvements in growth
rate and feed efficiency of the heifers with TBA (Heitzman et al, 1974; Galbraith,
1980; Stanton et al., 1988).
Estrogens. Estradiol is produced from aromatization of androgens and is
secreted from the ovaries of heifers and testes of bulls. Of all the steroids,
estrogens have the widest range of physiologic functions. Estrogens are involved
in reproductive activities and development of female secondary characteristics.
Nonreproductive effects of estrogens include stimulation of calcium uptake and
ossification of bones (Reeves, 1987). In ruminant animals, estrogens are the major
hormonal compounds used as growth promotants in the United States. These
compounds cause a release of growth hormone releasing factors from the
hypothalamus, which causes an increase in growth hormone (GH) secretion,
resulting in increased growth and nitrogen retention (Preston, 1975). Trenkle (1983)
reported that following exogenous estrogenic treatment, there was an increase in
plasma GH concentration and greater nitrogen retention and protein deposition.
VanderWal (1975a) conducted a study with Friesian bull calves and reported
on the effectiveness of anabolic agents in improving nitrogen retention and growth.
In normal veal calves, the percentage of digested feed protein converted to body
protein gradually decreased from 70% to less than 40% during the growing period.
By implantation with the most effective anabolic agent tested (20 mg estradiol and
140 mg TBA), the digested protein to body protein conversion over the trial period
of 38 days increased from 39% in the control to 58% in the implanted group. It
was concluded that the major reason for the extra weight gain obtained by
administration of anabolic agents was due to enhanced protein accretion resulting
from improved protein conversion efficiency. Estrogenic implants have been shown
to reduce testicle size and masculinity scores in bulls and at the same time improve
live weight gain (Brethour and Schanbacher, 1983, Schanbacher, 1984).
Presently, the exact mode of action of anabolic agents in relation to growth
is unclear, however there is supporting evidence that hormonal interactions are
responsible for the growth and behavioral differences among bulls, steers, and
heifers (Unruh, 1984). Hopefully, the results of these trials and future research
studies will assist in understanding the hormonal relationships of growth in cattle
production.
Anabolic Agents in Feedlot Cattle
Commercial Implants for Cattle. Thirty years of research and industry
experience has recognized that implanting with growth promoting hormones has
returned more dollars per dollar invested than any other management tool in the
livestock industry. Practically all cattle are given hormone implants upon arrival
at commercial feedlot facilities. The implantation of anabolic compounds is thought
by researchers to increase nitrogen retention, causing increased muscle growth and
decreased fat deposition. This allows the conversion of nutrients to muscle with
lower levels of energy and thus more efficient weight gain (Collins et al., 1989). In
animal production, anabolic agents are generally described in relation to their
classification (estrogenic, androgenic or progestogenic) or by whether they are
biologically endogenous or exogenous (Patterson and Salter, 1985). The implants
may contain estradiol, alone or in combination with progesterone or testosterone,
or they may contain zeranol, a synthetic drug with estrogenic activity. Currently in
the United States, there are several growth promoting compounds used in cattle as
shown in Table 1.
The following section of this review will focus on the commercial implants
that were used in this research which evaluated their effects on performance and
carcass characteristics of steers and heifers.
Ti-enbolone Acetate (Finaplix*). Trenbolone acetate is a growth promoting
implant (trade name Finaplix), a synthetic analogue of the male steroid testosterone.
Finaplix has FDA approval for both steers and heifers in feedlot growing-finishing
programs. Androgenic agents appear to increase protein accretion in muscle by
causing an anabolic effect upon protein metabolism to increase muscle growth
(Buttery et al., 1978). Brethour (1985) reported that implanting with 200 mg TBA
alone improved steer gains 9% over nonimplanted steers, but this was only about
half the response obtained with single implant treatments of the estrogenic implants,
Ralgro and Synovex-S. Trenkle (1987) indicated that TBA seems to increase
protein deposition by decreasing the rate of protein degradation. Heitzman and
Chan (1974) and Crouse et al. (1987) found that heifers implanted with TBA alone
increased growth and nitrogen retention. However, TBA seems to require the
presence of an estrogen in order to promote a maximum growth response
(Heitzman, 1976). Gainsworthy et al. (1986) indicated that TBA implantation of
cull dairy cows resulted in significantly higher (P<.01) live weight gains and tended
TABLE 1. TRADE NAME, MANUFACTURER, CHEMICAL COMPOUND AND U.S. FOOD
AND DRUG ADMINISTRATION (FDA) APPROVAL STATUS FOR ANABOLIC
GROWTH STIMULANTS IN THE UNITED STATES3
Chemical
Date
Approved
FDA Approval Status:
Trade
Name
Produced
By
Component
(Dosage) Calves Steers Heifers
Compudose Elanco Estradiol-170 (24 mg) 01/12/82 Yes Yes Yes
Finaplix-S Hoechst-
Roussel
Trenbolone
acetate (140 mg)
06/17/87 Yes
Finaplix-H Hoechst-
Roussel
Trenbolone
acetate (200 mg)
06/17/87 Yes
MGAb Upjohn Melengestrol
acetate (.25 - .50 mg
per day orally)
06/03/77 Yes
Ralgrob International
Minerals &
Chemical
Zeranol (36 mg) 11/05/69 Yes Yes Yes
Synovex-C Syntex Progesterone (100 mg)
& estradiol benzoate
(10 mg)
11/05/69 Yes
Synovex-H Syntex Testosterone
propionate (200 mg)
& estradiol benzoate
(20 mg)
07/16/58 Yes
Synovex-S Syntex Progesterone (200 mg)
& estradiol benzoate
(20 mg)
02/20/56 Yes
Steer-oid Anchor Labs Identical to Synovex-S 11/12/82 Yes
Heifer-oid Anchor Labs Identical to Synovex-H 07/24/84 Yes
aAdapted from Taylor (1984), McEvoy et al. (1987) and Collins et al. (1989).
bFor MGA, a 48-hour withdrawal period is required and for Ralgro, a 65-day withdrawal period
is required.
to increase (P=.06) feed intake compared with control cows over a 100-day feeding
period. In general, when TBA was used with an estrogenic implant, an additional
5 to 7% growth response was obtained (Galbraith and Geraghty, 1982; Heitzman,
1983; Brethour, 1985; Lobley et al., 1985; Steen, 1985; Trenkle, 1987).
Progesterone and Estradiol Benzoate (Synovex-S9 ). Progesterone is often
referred to as the hormone of gestation. It prepares the reproductive organs of the
female for pregnancy. The actions of progesterone outside of its reproductive
functions are largely unknown. Exogenous progestins are known to be anabolic in
beef cattle but the exact mechanism of this action is largely unknown. The main
sources of progesterone are the ovary and the placenta, although it is also found in
the adrenals and the testes where some secretion takes place. Metabolism of
gestagens vary among species but in ruminants most progesterone is converted to
androgens (Velle, 1975).
Estradiol has been shown to increase plasma levels of growth hormone which
in turn increases muscle and bone synthesis (Trenkle and Burroughs, 1978; Grigsby,
1981). Trenkle and Burroughs (1978) and Gopinath and Kitts (1981) indicated
that estradiol increased plasma levels of insulin which increases glucose and amino
acid uptake by the cells thereby stimulating protein synthesis. Estradiol has also
been reported to increase plasma levels of thyroxine which results in increased
metabolic and growth rates (Kahl et al., 1978; Rumsey et al., 1980).
Testosterone Propionate and Estradiol Benzoate (Synovex-H9). Synovex-H is
a growth stimulating implant for growing and finishing heifers. Mode of action of
the compounds in this implant has been discussed in the previous two sections.
In addition, testosterone is believed to have a direct effect on the muscle cell thus
exerting an anti-catabolic effect on muscle by slowing muscle breakdown (Vernon
and Buttery, 1976). Lobley et al. (1985) indicated that the anabolic effect of
trenbolone-estrogen implant combinations is primarily to decrease muscle protein
degradation rather than increase protein synthesis.
Zeranol (Ralgro9 ). Zeranol is an estrogen-like compound isolated from a
mold, gibberella zea, originally found in corn. It is a resorcylic acid lactone with
estrogenic activity (Heitzman, 1978). Zeranol's mode of action is not completely
clear, although there is evidence for an elevation of plasma growth hormone and
insulin concentrations in treated animals (Buttery et al., 1978). Trenkle and
Burroughs (1978) suggested zeranol may increase production of androgens from the
adrenal cortex, increase thyroid hormone activity, elevate GH secretion and have
a direct effect at the receptor site of target cells. Simms et al. (1988) studied the
effect of sequential implanting with Ralgro on steer lifetime performance. Results
indicated that implanting suckling calves did not reduce gains during the growing or
finishing phases of production. Similarly, finishing gains were not reduced when
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zeranol was implanted during the growing phase. Overall results verified a positive
impact of Ralgro implants on lifetime performance because steers receiving four
successive implants were 25 kg heavier (P<.05) than control steers at the time of
slaughter.
Trenkle (1983) concluded that androgens primarily act on muscle cells to
increase protein while the estrogens may stimulate GH secretions from the
hypothalamus and anterior pituitary.
Effects of Anabolic Agents on Cattle Growth
Response of Steers to Implantation. Implanting feedlot steers with anabolic
compounds is a common management practice for improving animal performance.
Not all species, or sex classes within a species, react to exogenous anabolic agents
with the same effectiveness (Vander Wal and Bererde, 1983). For example, when
feedlot steers are implanted with an estrogenic compound, rate of gain typically is
increased 8-15%, while feedlot heifers generally exhibit a 0-10% increase in gain
(Roche and Quirke, 1985; Roche, 1986). Under similar conditions of adequate
nutrition, bulls gain more quickly and efficiently than steers. This lowered
production due to castration has been attributed to reduced levels of endogenous
anabolic hormones in the steer (Field, 1971). Therefore, the use of exogenous
hormones or hormone-like compounds to improve beef production from steers has
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considerable interest. Galbraith and Watson (1978) conducted a study with 20
British Friesian steers and found a 25% increase in live weight gain with
implantation of hexoestrol (a synthetic estrogen) and a 41% increase in gain with
TBA and Hexoestrol compared to a control group during the final 70 days of the
experiment. The control steers were 22% and 37% less efficient than steers treated
with Hexoestrol alone and TBA plus Hexoestrol, respectively. Consequently, the
improvement in the live weight gain due to implant treatment may be directly
related to an improved feed efficiency. Their review concluded that these
compounds stimulated liveweight gain in ruminant animals and that the increase in
growth rates was related mainly to an increased deposition of protein tissue at the
expense of fat in the carcass.
Numerous research studies have shown that combining implants containing
compounds with androgenic and estrogenic activity are more effective in promoting
growth in steers then when these compounds are administrated separately
(Galbraith, 1982; Roche and Quirke, 1985; Brethour, 1986; Trenkle, 1987; Istasse,
1988). Roche and Davis (1978) studied the effects of TBA and zeranol, alone and
in combination, in steers. Each implant increased final liveweight, daily gain, and
carcass weight. When both implants were used in combination, there was an
additive effect, indicating that the two compounds act independently. This suggests
an independent mode of action or that a sub-maximal dose of one of the
compounds was given. Brethour (1985) reported that a combination of 200 mg
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TBA plus Synovex-S resulted in 26% faster steer gains than controls. Gains were
similar with a Ralgro + 200 mg TBA implant treatment and significantly (P<.05)
better than when no implants were used. Galbraith and Dempster (1979) reported
that TBA + Hexoestrol implanted Friesian steers gained 36% faster than untreated
animals in a 90-day trial. Fisher et al. (1986b) indicated the combination of
estradiol + TBA implanted in the same ear of steers was the most effective in
increasing growth rate, carcass weight, feed efficiency, and reducing fat deposition
as indicated by the weight of omental and perirenal fat. Galbraith et al. (1983)
reported British Friesian steers implanted with TBA + estradiol- 17/3 gained
significantly more live weight than controls with a 12 kg increase in the first 28-day
feeding period and a 23.5 kg advantage in gain over controls in a 56-day period.
Gropp et al. (1974) studied the effects of implantation on veal bull calves.
On the average, when implanted with estradiol and TBA the calves showed an
improvement of 14% in gain and 9% in feed efficiency in comparison to the control
group. Similar growth benefits have been reported in male veal calves implanted
with TBA and estrogenic compounds (Grandadam et al., 1975).
VanderWal et al. (1975b) also indicated similar results on performance of 563
Friesian bull calves. These calves were implanted with various anabolic agents at
11 weeks of age and maximum growth response was obtained with 20 mg estradiol
in combination with 140 mg trenbolone (Revalor). Calves gained 10.5, 15.8, 12.6,
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10.4, and 9.6 kg per calf by 4 to 5 weeks after various implant treatments, compared
with 4.1 kg gain per calf by 2 to 3 weeks after administration of 20 mg estradiol
alone.
There have been numerous studies comparing combination implant
treatments in ruminant animals. Sulieman et al. (1986) studied the response of
early weaned wether lambs (47 days of age) treated with various doses of TBA
combined with estradiol 17/3. On average, hormonal treatment resulted in
significant increases in live weight gain and feed intake. Differences in dose level
had little effect on growth and carcass characteristics. Sulieman et al. (1988)
reported similar results in live weight gain of 5 month old wether lambs implanted
with TBA and estradiol-17/3. The daily gain of control and implanted wethers was
273 g and 410 g, respectively (P<.001). Singh et al. (1984) observed that
implantation of trenbolone acetate and estradiol 11-/3 as a combined implant
(Revalor) increased liveweight gain and nitrogen retention in growing wether lambs.
However, response differences exist in the literature for the various
estrogenic compounds used in combination with trenbolone acetate. The
effectiveness of these compounds may have been influenced by dosage levels and
by variation in age, breed, time of castration and weight at the time of implantation
of the research animals (Johnson, 1987). Nonetheless, research studies have
indicated that TBA, in conjunction with estrogenic agents, does enhance growth and
that reimplanting stimulates an additional growth response (Lobley et al., 1985).
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Response of Heifers to Implantation. Traditionally, the beef industry has
discriminated against feeder heifers when compared to steers in the market place.
Price discrimination has probably been due to growth capabilities and feed
conversion being less efficient in heifers. The implantation of anabolic compounds
such as Synovex-H, Ralgro, and Compudose in heifers is widely practiced. Interest
in androgen implant treatments of heifers and the recent availability of trenbolone
acetate (Finaplix) has intensified research studies with this product (Schanbacher,
1984). In heifers, the ovaries are the primary glands which secrete endogenous
steroids that influence performance traits in cattle. The gonadal steroid in blood that
results in the fastest growth rates in young heifers is estrogen (Heitzman, 1976).
Feed efficiency and weight gain is lower in spayed feedlot heifers than in intact
heifers (Horstman et al., 1982). In practice, implants of estrogens and androgens,
such as trenbolone acetate, are used in heifers and cull cows to improve
performance. This usage of exogenous anabolic compounds and their interaction
with various endogenous hormones are believed to influence tissue growth and may
increase growth rate and efficiency of heifers to be comparable to steers (Crouse
et al., 1987).
Little et al. (1979) studied the effect of implanting prepuberal dairy heifers
with trenbolone acetate (T) or a combination of trenbolone acetate and estradiol-
17/3 (TE). Twenty-seven British Friesian heifer calves were implanted with T or TE
at 16 weeks and at 31 weeks of age. Body weight gains were not significantly
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different during the first implant treatment period, but gains were increased in the
T (P<.05) and TE (P<.01) groups, compared with controls, following the second
implant at 31 weeks of age. After 46 weeks, only the TE treatment group remained
significantly higher (P<.05) in body weight gain. Daily gains were as follows: T, .80
kg; TE, .87 kg; Control, .72 kg. Following both implant treatments, there was
increased nitrogen retention, as indicated by lower concentrations of urea in serum.
Galbraith (1980) conducted a study involving eight uniform Hereford X Friesian
heifers weighing approximately 365 kg. The heifers implanted with trenbolone
acetate showed a significant improvement in growth rate (P<.05) and feed
conversion (P<.01), with a 23% feed/gain response in treated animals. Mean live
weight gains were .7 and .8 kg/day for control and treated heifers, respectively.
Heitzman et al. (1974) conducted a similar study with twelve Friesian X Ayrshire
paired heifers ranging from 16 to 23 months of age. The heifers receiving
trenbolone acetate had an improved liveweight gain of 62.2 kg, and this was 25.6
kg (71% benefit) more than the control group during an eight week period.
Henricks et al. (1982) reported on the effect of a 300 mg TBA implant in heifers
for a long term (LT, 99-day) and short term (ST, 66-day) time period. Following
implantation with TBA heifers in the ST group gained faster (P<.05) than heifers
in the control or LT groups. Feed efficiency was not different (P>.10) among the
three groups, but there was a trend toward improved efficiency in the implant
treatment groups. Henricks suggested the reduced gain response of the LT group
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was due to the length of the implant period. During the first 5 weeks of the trial,
the LT group gained faster (P<.05) than the other two groups. The daily gains
were 1.11, 1.14, and 1.25 kg for the Control, ST, and LT groups respectively.
Extending the implant period may have nullified the effect on gain of the LT group.
Crouse et al. (1987) studied the response of ovariectomized (OVX) or intact
control heifers that were implanted with TBA alone or TBA in combination with
estradiol. Although not statistically significant, heifers implanted with TBA and
TBA plus estradiol, suggested improved gain and efficiency. The OVX treatment
group tended to have poorer feed efficiency which is consistent with other research
studies that have shown spayed heifers in feedlot conditions did not perform
comparably to intact heifers (Horstman et al., 1982). Hamernik et al. (1985)
reported that gain and feed efficiency of OVX heifers tended to be similar to intact
heifers and less than hysterectomized heifers. They concluded that the elevated
progesterone concentration from the maintained Corpora Lutea of hysterectomized
heifers was related to improved performance. Garnsworthy et al. (1986) indicated
that implanting cull dairy cows with TBA resulted in greater (P>.05) liveweight
gain-1.35 kg/day compared to 1.12 kg/day for the control group in a 60-day trial.
Animals fed for 100 days also resulted in greater daily gains in the TBA group
compared to controls (1.31 vs. .92 kg, P<.01).
Exogenous anabolic agents have demonstrated improved animal performance
in feedlot heifers. Researchers, due to its importance to the feedlot industry, will
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continue to assess the potential of currently available and newly developed
hormonal implants for use in feedlot heifers as well as steers.
Effect of Implants on Masculinity Traits of Steers and Heifers
Evaluation of masculinity traits as influenced by implants in feedlot steers and
heifers has been conducted to a limited extent and with varied results. Brethour
(1986) conducted a study that involved implantation of 200 mg TBA in combination
with Ralgro or Synovex-S. Implant treatments that included TBA produced obvious
masculine traits in steers including curly faces, broad heads, thick necks, prominent
crests, and some dark-cutting carcasses. Those traits were more pronounced when
steers were implanted with TBA 200 days before slaughter as compared to those
implanted within the last 60 days only. Masculine traits were especially evident
when TBA + Synovex-S was reimplanted twice following the initial implants.
Results of Fisher et al. (1986a) indicated that steers implanted with TBA did not
show development or muscle distribution comparable to bulls. Also, the use of
TBA in bulls showed no difference in muscle distribution compared to untreated
bulls. There was no effect of anabolic agents on the characteristic muscle weight
distribution of bulls. Galbraith and Watson (1978) indicated a slight raising of the
tailhead, depression of the loin, and teat development and elongation in steers
treated with Hexoestrol. Moreover, implantation with TBA tended to cause
thickening of the neck and increased shoulder development, although there was no
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obvious changes in behavior among steers. Little et al. (1979) indicated that
implanting prepuberal dairy heifers with TBA or a combination of TBA plus
estradiol- 17/3 markedly reduced udder size and suggested that TBA should not be
administered to prepuberal heifers which will be retained for breeding and milk
production.
Effects of Implants on Carcass and Meat Traits. The use of TBA in
combination with estrogenic agents has tended to increase carcass weight in steers
(Steen, 1985; Fisher et al., 1986a). Steen (1985) also indicated steers implanted
with TBA plus estrogenic compounds had slightly less kidney knob fat than control
steers, but observed no differences in ribeye area per unit carcass weight between
control and implanted steers. Silcox (1986) conducted a study with bulls and
reported that kidney, heart and pelvic fat was estimated to be .8 kg more for bulls
implanted with TBA and zeranol than control bulls, although similar ribeye areas
were found in control and implanted bulls. Brethour (1986) reported a trend
toward lower marbling score and carcass grade, and a higher incidence of dark-
cutting carcasses when implant combinations involved TBA in steers. Johnson and
Dikeman (1987) found that young bulls and steers implanted with TBA plus zeranol
had similar hot carcass weights, dressing percentages, carcass maturity scores, and
marbling scores. Steers and bulls implanted with TBA in combination with zeranol
tended to have more backfat, smaller ribeyes and higher yield grades than control
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bulls, but differences were not statistically significant. There were no differences
among treatment groups for lean firmness, texture and color, and a trained sensory
panel found no significant differences in flavor intensity, juiciness, overall tenderness,
or myofibrillar tenderness. Crouse (1987) conducted studies with heifers and
reported carcass muscle characteristics evaluated at the 12th rib interface, including
color, firmness, texture, and maturity, were similar among treatments involving TBA
Heifers implanted with TBA did not produce dark colored meat and carcasses
tended to possess less fat cover and a lower (P<.01) percentage of fat in soft tissue
of the 9-10-llth rib section than controls. Implanting heifers with TBA was
effective in reducing fat deposition and increased muscle mass.
Residue of Anabolic Agents in Meat Products
Chemical residues in red meat and poultry is a current concern for
consumers. This concern is not new to the livestock industry. For more than a
decade, the USDA Food Safety and Inspection Service (FSIS), supported by
consumer demands, have conducted a strong residue testing program. This National
Residue Program tests for residues of pesticides, drugs, and other chemical
contaminants in meat and poultry products. Overall, testing has detected very low
violative residues, representing about 1% of the total samples analyzed (USDA-
FSIS, 1988). No violative residues of currently approved implants have ever been
found in beef. Also, research studies have been conducted by commercial sponsors
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of anabolic implants, and their results have shown no significant residues of
hormonal drugs in implanted animals (Cordle, 1988). Toxicologists at the Food and
Drug Administration (FDA) have concluded that an increase in hormone level is
toxicologically insignificant if the residue in meat from implants containing naturally
occurring hormones do not exceed 1% of the daily production rate of these natural
hormones in prepuberal children (Farber and Arcos, 1983). Also, the FDA have
not required a regulatory testing method for residues prior to approval of these
implants (Farber et al., 1983). The scientific community has generally agreed that
proper use of approved exogenous anabolic compounds is of no risk to the
consumer and will enhance animal performance (Acha, 1983). In contrast to these
known acknowledgements, the European Economic Community (EEC) has imposed
an import ban on meat products from anabolically treated animals. Studies
conducted by the Lamming Committee, a scientific working group commissioned by
the EEC's own Scientific Advisory Committee, found no scientific evidence of risks
to consumers' health on this issue (Lamming, 1983). At that time, the committee's
recommendations of safety for anabolic agents use included: 1) the site of
application should be discardable, and 2) the withdrawal periods should be
observed. In 1987, this committee established hormone no-effect levels and
reported no evidence could be produced which would indicate that the use of any
currently approved anabolic agent in the U.S. caused risk to human health
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(Lamming, 1987). Nonetheless, the EEC has failed to recognize the findings of
their own committee commissioned by the Scientific Advisory Committee.
Prevention of residues in red meat products should be considered in all
phases of animal production and responsibility taken seriously by the livestock
industry to provide safe and wholesome products to the consumer.
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CHAPTERDI
EFFECTS OF FINAPLIX* LN COMBINATION WrTH
RALGRO* AND SYNOVEX® ON PERFORMANCE AND
CARCASS CHARACTERISTICS OF STEERS AND HEIFERS 1
ABSTRACT
Five field trials were conducted with 762 steers and heifers in cooperation
with four commercial feedlots to evaluate the effects of Finaplix in combination
with Ralgro or Synovex for growing and finishing programs. Implant dosage rates
used in the experimental treatments included: 1) Finaplix-S2, 140 mg trenbolone
acetate; 2) Finaplix-H2, 200 mg trenbolone acetate; 3) Ralgro 1 , 36 mg zeranol; 4)
Synovex-S3
,
200 mg progesterone and 20 mg estradiol benzoate; and 5) Synovex-H3 ,
200 mg testosterone propionate and 20 mg estradiol benzoate. In Trial 1, 176
spring-born Hereford steers averaging 223 kg were used to study sequential
implantation with Synovex-S (S) or Synovex-S + Finaplix-S (S+F) during wheat
grazing and the early and late finishing phases of this 267-d trial. During the 108-
d wheat pasture phase, the addition of Finaplix increased gains 8.2%. In the
appreciation is expressed to International Minerals and Chemical Co., Terra
Haute, IN, for financial support of this study.
2Hoechst-Roussel Agri-Vet Co., Somerville, NJ.
3Syntex Animal Health Inc., Des Moines, LA.
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subsequent early finishing phase, Finaplix treatment tended (P = .11) to increase
performance. The implant treatments used in the late finishing phase resulted in
no significant (P > .05) differences in daily gain and carcass characteristics.
However, when prior implant treatments were ignored by using orthogonal contrasts,
implanting with S+F increased (P < .05) average daily gain during both early and
late finishing phases, compared with S alone. Overall 267-d gain and carcass weight
were increased (P < .05), and marbling score was decreased (P = .06) when S+F
was used in the late finishing phase. In Trials 2 and 3, 374 yearling crossbred steers
were allotted to four finishing treatments: 1) Ralgro, 2) Ralgro plus Finaplix-S, 3)
Synovex-S and 4) Synovex-S plus Finaplix-S. Implant treatments did not
differentially affect gain, carcass weight, backfat thickness, percentage kidney, heart,
and pelvic fat or ribeye area in either trial. Finaplix use did not affect carcass
quality. However, in Trial 2, Synovex-implanted cattle had lower marbling scores
and fewer carcasses graded Choice (P < .05) compared to Ralgro steers. In Trial
4, 126 yearling heifers averaging 329 kg were implanted with Synovex-H initially and
allotted 49 d later to four finishing reimplant treatments: 1) no implant, 2)
Synovex-H, 3) Finaplix-H or 4) Synovex-H plus Finaplix-H. Reimplanting heifers
had no effect on gain or carcass characteristics, except for the percentage grading
Choice, which was reduced (P < .05) in the F and S+F groups. Hide weights and
hide pull scores tended to be increased slightly in the heifers implanted with
Finaplix. In Trial 5, 86 crossbred steer calves averaging 227 kg were allotted to two
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implant treatments: 1) Ralgro alone or 2) Ralgro plus Finaplix-S. In this 77-d
drylot growing trial, a 5.4% gain response was obtained with Finaplix plus Ralgro
as compared to Ralgro alone. In general, effects of Finaplix on cattle performance
were inconsistent across trials. However, implanting cattle with Finaplix and either
Ralgro or Synovex tended to result in increased gain, final weight, and carcass
weight, with little effect on backfat thickness, ribeye area or percentage kidney,
heart, and pelvic fat observed, when compared to cattle receiving only estrogenic
implants. Marbling score and the percentage of cattle grading Choice tended to be
reduced slightly, although this was not usually significant.
Key words: Steers, Heifers, Anabolic Implant, Performance, Carcass.
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INTRODUCTION
Hormonal implants have been approved and used by the beef industry since
the mid 1950's. The use of estrogenic growth promoting implants is now a common
management practice for cattle producers and commercial feedlots. These products
increase rate of gain and improve feed efficiency which results in a lower cost of
production and increased profitability for the producer (Trenkle, 1987).
The recent clearance of Finaplix, a synthetic testosterone-like implant for
feedlot growing-finishing steers and heifers has stimulated a great deal of interest
in its growth-promoting effects when used in conjunction with estrogenic implants.
There has been considerable speculation that Finaplix may reduce carcass quality
by reducing marbling, and increase the incidence of dark cutters (Brethour, 1986).
Additionally, some packers have suggested that cattle implanted with Finaplix may
have heavier hides that pull harder, resulting in problems during slaughter.
Therefore, these trials were conducted to compare cattle performance and carcass
characteristics using Finaplix in combination with Ralgro or Synovex implants under
commercial feeding conditions.
EXPERIMENTAL PROCEDURES
Five field trials were conducted with 762 steers and heifers in cooperation
with four commercial feedlots. Implant dosage rates involved in the experimental
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treatments included: 1) Finaplix-S, 140 mg trenbolone acetate; 2) Finaplix-H, 200
mg trenbolone acetate; 3) Ralgro, 36 mg zeranol; 4) Synovex-S, 200 mg
progesterone and 20 mg estradiol benzoate; and 5) Synovex-H, 200 mg testosterone
propionate and 20 mg estradiol benzoate. All implants were inserted with a needle
subcutaneously between the skin and cartilage in the middle of the posterior side
of the ear. Of the implants used in these trials, only Ralgro required a withdrawal
period of 65 d prior to slaughter. Finaplix-H was labelled for use in feedlot heifers
only during approximately the last 63 d prior to slaughter. Finaplix-S was labelled
for use in feedlot steers with a suggested reimplantation once after about 63 d.
The experiments conducted included one drylot growing trial, three finishing
studies, and one trial that consisted of a wheat pasture, and early and late finishing
phases. The length of the feeding periods varied from 77 to 267 d among trials.
However, all cattle within a given trial were fed the same number of days. All
cattle received standard processing treatments at the start of the trials, which
included ear tagging, weighing, vaccinating and treatment for internal and external
parasites. Individual unshrunk weights were collected at initial and reimplant times,
and final weights were calculated from hot carcass weights and average dressing
percentage slaughter in the finishing trials. Overall feed consumption and efficiency
was determined on a feedlot pen basis only. After slaughter at a commercial
packing plant, carcasses were chilled for approximately 24 h before carcass
characteristics were evaluated.
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Individual THals
Thai 1. In Trial 1, 176 Hereford spring-born steer calves from one
commercial ranch were used. The first phase of this 267-d trial included a 108-d
grazing phase on wheat pasture starting on November 14, 1987. The steer calves,
averaging 223 kg initially, were allotted randomly to two implant treatments: 1)
Synovex-S alone (S) or 2) Synovex-S plus Finaplix-S (S+F). For the second phase
of the trial, the steers were transported to a feedlot to begin the 86-d drylot early
finishing program. At the start of the early finishing phase, the steers were
individually reweighed and reallotted to four reimplant treatments with either S or
S+F. At the start of the 73-d late finishing phase, the steers were individually
weighed, reallotted within previous implant treatments and reimplanted with either
S or S+F such that all possible sequential implant alternatives were studied during
the wheat pasture, and early and late finishing phases. During the early finishing
phase the steers were fed the following ration: 33% steam flaked (SF) milo, 25%
SF wheat, 20% SF corn, 8% alfalfa hay, 4.3% wheat mid pellets, 3.5% molasses,
3.2% premix and 3% fat. The late finishing ration contained 59% SF milo, 8%
alfalfa hay, 3.5% molasses, 3.3% wheat mid pellets, 3.2% premix and 2.5% fat.
After slaughter, carcasses were chilled for approximately 24 h prior to determination
of carcass weight, backfat thickness, ribeye area, percentage KHP (kidney, heart and
pelvic) fat, marbling score, and quality and yield grades.
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Thai 2. On May 5, 1988, 273 yearling crossbred steers averaging 366 kg
were started on a finishing trial at a commercial feedlot. The steers were visually
sorted into three weight groups and fed in three separate pens. The steers in each
pen were individually weighed and allotted randomly to four finishing implant
treatments: 1) Ralgro, 2) Ralgro plus Finaplix-S, 3) Synovex-S and 4) Synovex-S
plus Finaplix-S. The steers were fed an ad libitum ration consisting of the following
ingredients: 83.25% rolled corn, 6% sorghum silage, 5% alfalfa, 3% molasses and
2.75% protein supplement. Of the 273 animals, one pen (64 steers) was slaughtered
after a 99-d feeding period, and the other two pens (209 head) were slaughtered
after 109 d on feed. After slaughter, the carcasses were evaluated for hot carcass
weight, backfat thickness, percentage KHP fat, ribeye area, marbling score, quality
and yield grades and incidence of dark cutters. Individual carcasses were graded
for dark cutter characteristics based upon the color intensity of the ribeye surface,
and divided into quarter grades as follows: 1/4, 1/2, 3/4, and full dark (Ray, 1977).
Dial 3. In Trial 3, 101 yearling steers averaging 378 kg were fed 97 d on a
finishing program at a commercial feedyard. The trial began September 2, 1988,
when the steers were individually weighed and randomly assigned to four finishing
implant treatment groups: 1) Ralgro, 2) Ralgro plus Finaplix-S, 3) Synovex-S and
4) Synovex-S plus Finaplix-S. The finishing ration consisted of: 82.5% cracked
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corn, 8.5% alfalfa hay, 6% liquid protein supplement, and 3% of a molasses and
blended fat mixture. After the cattle were slaughtered, carcass traits were evaluated
including hot carcass weight, backfat thickness, ribeye area, percentage KHP fat,
marbling score, quality and yield grades, and incidence of dark cutters.
THal 4. In Trial 4, 126 yearling, predominantly British-bred heifers averaging
329 kg were utilized in a finishing study. At the beginning of the 127-d finishing
period, on August 3, 1988, the heifers were group-weighed and implanted with
Synovex-H. After 49 days on feed, heifers were individually weighed and randomly
reimplanted as follows: 1) no implant, 2) Synovex-H, 3) Finaplix-H and 4) Synovex-
H plus Finaplix-H. The heifers were were fed melengestrol acetate (MGA; .5 mg
daily) throughout the trial. The composition of the finishing ration included 50%
SF corn, 31% SF milo, 8% alfalfa hay, 5% molasses, 4% premix and 2% fat. At
the end of the feeding period, the cattle were sorted at the feedlot into the four
implant treatment groups and weighed prior to slaughter. Group hide weights and
individual hide pull characteristics were recorded. Hide weights were evaluated as
a percentage of live animal weight by treatment groups. Hide pull characteristics
were based on the difficulty of mechanically pulling the hides, appraised visually
by a trained observer, on a 1 to 5 scale with 5 being most difficult. In addition,
carcasses were evaluated for hot carcass weight, back fat, percent KHP fat, ribeye
area, marbling score, quality and yield grades and incidence of dark cutters.
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THal 5. In this trial, 86 crossbred steers averaging 227 kg were fed on a corn
silage-based growing program at a commercial preconditioning yard. On November
23, 1987, the steers were initially weighed and allotted to two implant treatments:
1) Ralgro alone or 2) Ralgro plus Finaplix-S. At the end of the 77-d growing trial,
the steers were individually reweighed.
Statistical Analysis. Data were evaluated by analysis of variance and means
were separated using the least squares means procedure of the General Linear
Models (GLM) procedure of the Statistical Analysis System package (SAS,1985).
Wherever appropriate, initial weight and breed type were included as covariates in
the model. In Trial 1, hypotheses about the means were tested using orthogonal
contrasts. Results are reported as least squares means. The percentage of Choice
carcasses in each trial was analyzed by the Chi Square distribution method.
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RESULTS
Trial 1
Animal Performance and Carcass Characteristics. In Trial 1, Synovex-S plus
Finaplix-S (S+F) increased (P<.05) steer gain over Synovex-S (S) alone during the
108-d wheat pasture phase (Table 2). Average daily gain (ADG) was .61 vs .66
kg for S and S+F, respectively, which resulted in an 8.2% response for calves
implanted with Finaplix.
During the early finishing phase, there was no significant (P>.05) effect on
gain among the implant treatment groups. However, steers implanted with S+F
exhibited higher (P=.ll) ADG than those implanted with S alone. Similar trends
in ADG were observed in the finishing phase. When prior implant treatments were
ignored by using orthogonal contrasts, S+F significantly increased (P<.05) steer
ADG during both early finishing (1.43 vs 1.36 kg) and late finishing (1.50 vs 1.41 kg)
phases compared to S alone (Table 3). Implanting with S+F increased (P<.05)
steer final weight (525 vs 513 kg) and overall daily gain (1.13 vs 1.09 kg) as
compared to S alone. An additional data analysis was conducted on steer
performance during the early and late finishing periods, ignoring the prior wheat
pasture phase. This analysis evaluated the sequence of implant alternatives and
considered the implantation of S followed by reimplanting with S or S+F, or the
implantation of S+F followed by S or S+F. Reimplantation with S after S+F had
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TABLE 2. EVALUATION OF SYNOVEX OR SYNOVEX PLUS FINAPLIX
COMBINATIONS ON STEER PERFORMANCE DURING WHEAT PASTURE,
AND EARLY AND LATE FINISHING PHASES (TRIAL 1)
Wheat Pasture Treatments: S 1 S+F1
No. Steers 88 88
Initial Wt, kg 222 222
Ending Wt, kg 289 294
Daily Gain, kg .61a .66"
/ \ / \
Early Finishing
Treatments: S S+F S S+F
No. Steers i60 28 31 57
Ending Wt, kg 408 416 408 415
Daily Gain, kg 1.39 1.44 1.32 1.41
/ \
1 1
/ \
Late Finishing
Treatments: S S+F S+F
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S S
26
S+F
No. Steers 30 30 31 31
Daily Gain, kg 1.45 1.54 1.46 1.43 1.34 1.49
Final Wt, kg 513 522 525 514 513 527
Carcass Wt, kg 323 329 330 324 323 332
Backfat thick-
ness, cm 1.35 1.50 1.42 1.37 1.42 1.27
KHP Fat, % 2.25 2.25 2.19 2.30 2.30 2.13
Ribeye Area, sq cm 84.5 84.5 85.8 85.2 84.5 89.7
REA/cwt, sq. cm/
100 kg2 26.2 25.9 26.2 26.4 26.3 27.0
Yield Grade 2.81a 2.99s 2.84a 2.78ab 2.88a 2.50b
Marbling Score3 165 167 155 164 172 146
% Choice 13a 13a lla 19a 31b 103
Overall Daily Gain, kg 1.09 1.12 1.13 1.08 1.09 1.15
Steers were implanted sequentially with either Synovex-S alone (S) or Synovex-S plus
Finaplix-S (S+F).
2Ribeye area per 100 kg hot carcass weight.
3100-199 = slight, 200-299 = small, 300-399 = modest degrees of marbling.
abValues in the same row with unlike superscripts differ (P<.05).
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TABLE 3. EFFECTS OF SYNOVEX OR SYNOVEX PLUS FINAPLIX ON STEER
FINISHING PERFORMANCE IGNORING PREVIOUS IMPLANT
TREATMENTS (TRIAL 1)
Synovex +
Item Synovex (S) Finaplix (S+F)
Early Finishing Phase Treatments:
No. Steers 91 85
Daily Gain, kg 1.36a 1.43b
Late Finishing Treatments:
No. Steers 87 89
Daily Gain, kg 1.41 a 1.50b
Final Wt, kg 513a 525b
Carcass Wt, kg 323a 330b
Backfat Thickness, cm 1.38 1.40
Ribeye Area, sq. cm 84.7 86.7
REA/cwt, sq. cm/100 kg1 26.2 26.3
KHP Fat, % 2.28 2.19
Marbling Score2 167 156
% Choice 21a llb
Overall Daily Gain, kg 1.09* 1.13b
1Ribeye area per 100 kg hot carcass weight.
2100-199 = slight, 200-299 = small, 300-399 = modest degrees of marbling.
abValues with unlike superscripts differ (P<.05).
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a negative (P<.02) effect on ADG compared to reimplantation with S+F. When
overall finishing performance was evaluated by combining both early and late
finishing periods, lower (P<.02) gains were associated with reimplantation with S
alone following initial implantation with S+E Reimplantation with S+F produced
higher (P<.03) overall finishing gains.
Unfortunately, feed conversion could not be obtained for each implant
treatment since the steers were fed together in one commercial feedlot pen.
Overall feed conversion for all steers in the finishing period was 5.72 on a dry
matter basis.
Implanting with S+F compared to S alone did not affect (P>.05) carcass
weight, backfat thickness, ribeye area per 100 kg hot carcass weight (REA/cwt), or
percentage of KHP fat. Ribeye area was increased (P=.08), yield grade decreased
(P=.06) and marbling reduced (P=.14) due to S+F treatment. By using orthogonal
contrasts, consideration was given only to two treatments, F+S or S as final
implants. This analysis showed that carcass weight was significantly (P<.05)
increased (330 vs 323 kg) with S+F compared to S alone. There was a reduction
(P=.06) in marbling score by S+F use in the late finishing phase. Repeated
implantation with the combination of S+F had little effect on carcass characteristics
compared to S alone, although ribeye area increased (P=.08) and marbling score
and percentage Choice reduced (P=.14). When analysis was conducted on implant
treatments during the early and late finishing periods, ignoring prior wheat pasture
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treatments, marbling score was reduced (P<.05) with sequential implantation of
S+F during the early and late finishing phases, compared to other treatments. Also
in this analysis, ribeye area was increased (P<.07) with early and late implantation
of S+E
1Hal2
Animal Performance and Carcass Characteristics. In Trial 2, ADG of feedlot
steers were 1.49, 1.50, 1.48 and 1.53 kg for Ralgro (R), Ralgro + Finaplix (R+F),
Synovex-S (S) and Synovex-S + Finaplix-S (S+F), respectively (Table 4).
Differences in gains among treatments were not significant (P>.05), although there
tended to be an increase in ADG in the S+F group compared to the S alone.
Finaplix use in combination with estrogenic implants did not affect carcass
traits including carcass weight, backfat thickness, ribeye area, REA/cwt, or
percentage KHP fat. However, Synovex-S implanted cattle had lower marbling
scores and fewer graded Choice (P<.05) compared to Ralgro implanted steers.
This trial also compared the percentage of dark cutters among treatment
groups since this is an important factor in determining carcass quality and economic
value. The incidence of dark cutters (DK) in each implant group were: R, one 1/4
DK and one 1/2 DK; R+F, one 1/4 DK and one 1/2 DK; S, three 1/4 DK, one 3/4
DK and one full dark cutter; and S+F, six 1/4 DK, one 1/2 DK, one 3/4 DK and
two full dark cutters. There was a general trend for increased dark cutters in the
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TABLE 4. EFFECT OF RALGRO AND SYNOVEX, WITH OR WTTHOUT
FINAPLIX, ON PERFORMANCE OF FEEDLOT STEERS (TRIAL 2)
Ralgro + Synovex +
Item Ralgro Finaplix Synovex Finaplix
No. Steers 67 70 71 65
Inital Wt, kg 367 366 366 366
Final Wt, kg 522 522 520 524
Daily Gain, kg 1.49 1.50 1.48 1.53
Carcass Wt, kg 328 329 327 330
Backfat thickness, cm 1.37 1.35 1.35 1.27
Kidney Fat, % 1.87 1.85 1.85 1.84
Ribeye Area, sq cm 79.4 79.4 80.0 81.9
REA/cwt,
sq. cm/100 kg 1 24.3 24.3 24.4 24.9
Yield Grade 3.02 3.00 2.97 2.81
Marbling Score2 21 la 202ab 192bc 181c
% Choice 48a 49a 31b 27b
!Ribeye area per 100 kg hot carcass weight.
2100-199 = slight, 200-299 = small, 300-399 = modest degrees of marbling.
abcValues in the same row with unlike superscripts differ (P<.05).
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S and S+F implanted cattle. Cattle were slaughtered in August at a time of
extreme heat stress.
Dial 3
Animal Performance and Carcass Characteristics. The experimental design of
this trial was similar to Trial 2. Implant treatments resulted in no (P>.05) effect
on steer ADG, although gain tended to be increased when Finaplix was used in
conjunction with Ralgro or Synovex-S (Table 5). Average daily gains were: R, 1.73;
R+F, 1.79; S, 1.68; and S+F, 1.76 kg. Overall pen feed conversion to live weight
gain was 6.90 on a dry matter basis.
There was no (P>.05) effect of implant treatments on carcass characteristics
in this trial. Although not significant, there tended to be a slight increase in carcass
weight with the combination implant treatments. The incidence of dark cutters in
each implant group was minimal with only one carcass scoring a 1/2 DK in the
R+F group. Results were very similar among treatment groups in backfat
thickness, percentage KHP fat, ribeye area, REA/cwt, yield grade, marbling score
and percentage of Choice carcasses.
Trial 4
Animal Performance and Carcass Characteristics. Trial 4 was the only study
that involved heifers, and the results are presented in Table 6. Reimplanting heifers
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TABLE 5. EFFECT OF RALGRO AND SYNOVEX ALONE AND IN
COMBINATION WITH FINAPLIX, ON FINISHING STEER
PERFORMANCE (TRIAL 3)
Ralgro + Synovex +
Item Ralgro Finaplix Synovex Finaplix
No. Steers 24 25 26 26
Initial Wt, kg 378 377 378 378
Final Wt, kg 546 551 541 548
Daily Gain, kg 1.73 1.79 1.68 1.76
Carcass Wt, kg 349 353 346 351
Backfat Thick-
ness, cm 1.19 1.19 1.19 1.24
KHP Fat, % 1.94 2.25 2.09 1.91
Ribeye Area, sq. cm 84.5 86.5 87.1 85.2
REA/cwt,
sq. cm/100 kg 1 24.2 24.7 25.3 24.4
Yield Grade 2.81 2.80 2.67 2.81
Marbling Score 1 194 167 185 190
% Choice 50 44 46 54
!Ribeye area per 100 kg hot carcass weight.
2100-199 = slight, 200-299 = small, 300-399 = modest degrees of marbling.
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TABLE 5. EFFECT OF REIMPLANTING WITH FINAPLIX AND SYNOVEX, USED
SINGLY OR IN COMBINATION, ON HEIFER PERFORMANCE (TRIAL 4)
Initial Imdant / Reimnlant
Synovex Synovex Synovex Synovex
Item None Synovex Finaplix Synovex + Finaplix
No. Heifers 33 31 31 31
Initial Wt, kg 329 329 329 329
Reimplant Wt, kg 389 389 389 389
Final Wt, kg 501 497 496 499
Daily Gain, kg 1.43 1.38 1.38 1.42
Carcass Wt, kg 306 304 302 306
Backfat, cm 1.17 1.14 1.19 1.30
Kidney Fat, % 2.41 2.51 2.05 2.37
Ribeye Area, sq. cm 86.5 83.2 85.8 84.5
REA/cwt, wq. cm/100 kg1 28.3 27.4 28.3 27.9
Yield Grade 2.40 2.54 2.38 2.63
Marbling Score2 323 280 256 278
% Choice 97a 94ab 87bc 77c
Hide Pull Score3 2.0 2.0 2.3 2.2
Hide Wt, % of Live Wt 5.9 6.2 6.5 6.2
Ribeye area per 100 kg hot carcass weight.
2100-199 = slight, 200-299 = small, 300-399 = modest degrees of marbling.
3 Difficulty of mechanically pulling hides at slaughter appraised visually on a 1 to 5 scale,
5 = most difficult.
abcValues with unlike superscripts differ (P<.05).
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78 d before slaughter with either Synovex-H (S), Finaplix-H (F), or a combination
of Synovex-H and Finaplix-H (S+F) had no (P>.05) effect on ADG. Heifer ADG
were: control, 1.43; S, 1.38; F, 1.38; and S+F, 1.42 kg. Overall feed conversion to
live weight gain averaged 6.37 on a dry matter basis.
Implant treatments resulted in no (P>.05) effect on hot carcass weight,
backfat thickness, ribeye area, REA/cwt or yield grade. However, the F reimplant
group had a reduced (P=.08) percentage of KHP fat and lower (P=.16) marbling
score. This trial indicated reduction (P<.05) in the percentage of animals grading
Choice in the F and S+F groups compared to controls. There was no incidence of
dark cutters among implant treatment groups.
In this heifer study, hide pull scores and group hide weights were evaluated
among implant treatments. Although not (P>.05) significant, hide weights and hide
pull scores tended to be increased slightly by treatments including Finaplix.
Dial 5
Animal performance. In the 77-d growing study, ADG were 1.10 vs 1.16 kg
for Ralgro and Ralgro plus Finaplix treatment groups, respectively (Table 7). This
resulted in a 5.4% gain response with the Finaplix combination treatment. Carcass
characteristics were not obtained in this growing feeding trial.
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TABLE 7. INFLUENCE OF RALGRO AND FINAPLDC ON GROWING STEER
GAINS (TRIAL 5)
Item Ralgro Alone Ralgro + Finaplix
Initial Wt, kg 227 227
Final Wt., kg 312 316
Total Gain, kg 84.9 89.4
Daily Gain, kg 1.10 1.16
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DISCUSSION
Animal Performance. Implantation with Synovex-S plus Finaplix-S (S+F)
increased (P<.05) steer gain over Synovex-S (S) alone during a 108-d wheat pasture
grazing program. Brethour (1985) also reported positive findings in a pasture study
involving the combination of Ralgro plus trenbolone acetate (TBA). His results
included an increase (P<.01) in gain of 33.6% over non-implanted steers and a
17.6% advantage in gain over solitary Ralgro implantation. Roche and Davis (1978)
also found that implantation with 300 mg TBA alone increased (P<.01) ADG,
resulting in pasture gains of .88 vs. 1.05 kg for control and Finaplix groups,
respectively. Our results are in contrast to those of Brandt (1988) who conducted
an 85-d wheat pasture grazing study and found no difference in daily gains of steers
implanted with S or the combination of S+F. However, steers implanted with S,
F, or S+F were 7.7% higher (P<.05) than nonimplanted steers.
In the drylot growing study, steers implanted with (R+F) gained 5.4% faster
than (R) steers. This finding is similar to that of Brethour and Schanbacher (1983),
who indicated that implantation of R+F in prepubertal bulls resulted in an 11%
increase in gain. Grandadam (1975) reported similar results with Friesian veal
calves in which ADG was increased 17.4% over controls with implantation of TBA
plus estradiol- 17-/3.
Results of these studies and previously cited trials illustrate that the use of
Finaplix in combination with estrogenic compounds in growing programs offers
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inconsistent improvement in performance. The explanation for variable response
is not readily available. However, variation in growing steer performance is
influenced by factors such as growth potential, level of nutrition, and the level of
hormonal activity in the forage. Research evaluation of the interaction of these
factors with implants is limited and has not shown any clear relationships (Simms
et al, 1988).
In the finishing phase of Trial 1, when prior implant treatments were ignored
by using orthogonal contrasts, S+F significantly increased (P<.05) steer ADG
compared to S alone. This is in agreement with numerous researchers who have
demonstrated TBA in combination with an estrogenic implant improves daily gain
and feed efficiency in steers (Galbraith and Geraghty, 1982; Heitzman, 1983; Lobley
et al., 1985; Steen, 1985). Our findings are similar to those of Brandt (1988), who
conducted a 119-d finishing trial comparing the effects of implants on performance
and found that steers implanted with S+F gained faster (P<.05) than those given
S alone.
In Trials 2 and 3, implanting with Finaplix in combination with either Ralgro
or Synovex did not significantly improve ADG of finishing steers. Johnson and
Dikeman (1987) indicated similar findings with 200 mg TBA in combination with
Ralgro. Their results showed no differences in ADG among treatments with bulls
and steers. These results are in contrast to other previous studies that found
significant improvement in live animal performance with TBA in combination with
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estrogenic compounds (Galbraith, 1982; Galbraith, 1983; Brethour, 1986; Bohorov,
1987; Istasse, 1988). Results from Trials 2 and 3 indicate that Finaplix in
combination with Ralgro or Synovex offers an inconsistent improvement in finishing
performance. One possible explanation for this finding is that Finaplix was
administered only once at the beginning of these finishing trials. Moreover, the
dosage rate used (140 mg TBA) was lower than that employed in most previous
studies. Several studies, especially in the European countries have administered
TBA at the dosage rate of 200 to 300 mg to steers in finishing programs.
Reimplanting with Finaplix or Synovex plus Finaplix did not improve (P>.05)
ADG of finishing heifers. These results are in contrast to several research studies
which have indicated a increased (P>.05) growth rate with implantation of TBA in
combination with estrogenic compounds (Heitzman and Chan, 1974; Little et al.,
1979; Galbraith, 1980; Henricks et al., 1982). Crouse (1987) reported that, although
not (P>.05) statistically significant, heifers implanted with estradiol plus TBA had
greater live weight gain than other treatment groups.
In Trial 1, implantation with S+F in the wheat pasture growing phase did
not reduce finishing performance. This trial indicated a positive growth effect from
Finaplix implantation in the early and late finishing phases. Brethour (1985)
reported that implanting steers with TBA plus estrogenic agents in the growing
phase improved performance and did not adversely affect subsequent feedlot gain
or carcass quality. Simms et al. (1988) reported similar findings on the effect of
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sequential implanting with zeranol on lifetime performance. Animals receiving four
successive Ralgro implants were 25 kg heavier (P<.05) than control steers at the
time of slaughter.
In Trial 1, it was observed that the sequential implantation with S+F
followed by S alone resulted in reduced daily gain. This suggests that once Finaplix
use has been initiated, it should be repeatedly administered at regular intervals until
slaughter.
Carcass Characteristics. Carcass data were collected on four of the five trials
in this study. In three of the four trials, implanting with Finaplix did not increase
(P>.05) carcass weight. However, in Trial 1, when prior implant treatments were
ignored by using orthogonal contrasts, implanting with Finaplix significantly increased
carcass weight. Roche and Davis (1978) also found increased carcass weight in
steers with TBA use. Steen (1985) also reported an increase in carcass weight with
TBA in combination with Ralgro or estradiol.
In the four trials, implantation with Finaplix or Finaplix in combination with
either Ralgro or Synovex had no (P>.05) effect on backfat thickness, ribeye area
or percentage of KHP fat. However, in Trial 1, ribeye area was increased (P=.08)
in the Finaplix treatment groups. In the heifer study, the percentage of KHP fat
was decreased (P=.08) in the Finaplix treatment group. Steen (1985) indicated that
KHP fat and ribeye area were not significantly affected by Finaplix use in steers.
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Crouse (1987) reported that heifers implanted with TBA possessed less fat cover
and also had a lower (P<.01) percentage of fat in the soft tissue of the 9-10-llth
rib section than controls.
In regard to marbling, Finaplix implanted cattle in two of the four trials
tended to have reduced marbling scores (P=.06 to .16). An interesting result in
Trial 2 was the reduction (P<.05) in marbling score and percentage of Choice
grading steers when implanted with S or S+F as compared to Ralgro or Ralgro plus
Finaplix. This finding is in agreement with those of Brethour (1986). The
percentage of cattle grading Choice was reduced (P<.05) with implantation of
Finaplix in the heifer trial. In Trial 1, the percentage of Choice cattle tended to be
reduced (P=.14) with repeated S+F use. Brethour and Schanbacher (1983) and
Fisher et al.( 1986b) also reported that TBA in combination with estradiol tended
to reduce marbling score and carcass grade. Brethour (1986) indicated a trend
toward lower marbling score and quality grade in steers when Finaplix was used in
combination with Ralgro or Synovex.
The incidence of dark cutting carcasses were evaluated in three of the four
finishing trials. There was little effect of Finaplix on dark cutters. However, it was
interesting that in the summer finishing trial, there was a higher incidence of dark
cutting carcasses with steers implanted with Synovex or Synovex plus Finaplix
compared to Ralgro or Ralgro plus Finaplix implant groups. Brethour (1986)
indicated a similar finding with steers implanted with TBA in combination with
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Synovex in one trial. In his subsequent trials, cattle were slaughtered immediately
upon arrival at the packing plant which seemed to reduce stress and no additional
dark cutters were observed. In order to evaluate these findings, further research
should be considered to determine the effects of Synovex and Synovex plus Finaplix
during summer feeding periods.
In the heifer trial, hide pull score and hide weight as a percentage of live
weight were evaluated. Although not significant (P>.05), there was a tendency for
increased difficulty in hide pull and increased hide weight in heifers implanted with
Finaplix. Fisher et al. (1986) reported that steers implanted with TBA and
estradiol-170 had slightly heavier hides and reproductive organ weights. Our
findings are similar to those of Apple (1989) who found that implantation of
Synovex or Ralgro in combination with Finaplix increased hide pull scores.
Conclusions. The results of our study indicate that the effects of Finaplix on
cattle performance and carcass characteristics were inconsistent across trials.
However, in general, implanting cattle with Finaplix, in combination with either
Ralgro or Synovex tended to result in increased gain, final weight and carcass
weight, with little effect on backfat thickness, ribeye area, or KHP fat. Hide weight
and hide pull scores tended to be increased with Finaplix use, while marbling score
and the percentage of cattle grading Choice tended to be reduced slightly, although
this was usually not significant.
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ABSTRACT
Five field trials were conducted with 762 steers and heifers in cooperation
with four commercial feedlots to evaluate the effects of Finaplix in combination with
Ralgro or Synovex for growing and finishing programs. Implant dosage rates used
in the experimental treatments included: 1) Finaplix-S, 140 mg trenbolone acetate;
2) Finaplix-H, 200 mg trenbolone acetate; 3) Ralgro, 36 mg zeranol; 4) Synovex-S,
200 mg progesterone and 20 mg estradiol benzoate; and 5) Synovex-H, 200 mg
testosterone propionate and 20 mg estradiol benzoate. In Trial 1, 176 spring-born
Hereford steers averaging 223 kg were used to study sequential implantation with
Synovex-S (S) or Synovex-S + Finaplix-S (S+F) during the wheat grazing, and the
early and late finishing phases of this 267-day trial. During the 108-day wheat
pasture phase, the addition of Finaplix increased gains 8.2%. In the subsequent
early finishing phase, Finaplix treatment tended (P = .11) to increase performance.
The implant treatments used in the late finishing phase resulted in no significant (P
> .05) differences in daily gain and carcass characteristics. However, when prior
implant treatments were ignored by using orthogonal contrasts, implanting with S+F
increased (P < .05) average daily gain during both early and late finishing phases,
compared with S alone. Overall 267-day gain and carcass weight were increased
(P < .05), and marbling score was decreased (P = .06) when S+F was used in the
late finishing phase. In Trials 2 and 3, 374 yearling crossbred steers were allotted
to four finishing treatments: 1) Ralgro, 2) Ralgro plus Finaplix-S, 3) Synovex-S and
4) Synovex-S plus Finaplix-S. Implant treatments did not differentially affect gain,
carcass weight, backfat thickness, percentage kidney, heart, and pelvic fat or ribeye
area in either trial. Finaplix use did not affect carcass quality. However, in Trial
2, Synovex-implanted cattle had lower marbling scores and fewer carcasses graded
Choice (P < .05) compared to Ralgro steers. In Trial 4, 126 yearling heifers
averaging 329 kg were implanted with Synovex-H initially and allotted 49 days later
to four finishing reimplant treatments: 1) no implant, 2) Synovex-H, 3) Finaplix-
H or 4) Synovex-H plus Finaplix-H. Reimplanting heifers had no effect on gain or
carcass characteristics, except for the percentage grading Choice, which was reduced
(P < .05) in the F and S+F groups. Hide weights and hide pull scores tended to
be increased slightly in the heifers implanted with Finaplix. In Trial 5, 86 crossbred
steer calves averaging 227 kg were allotted to two implant treatments: 1) Ralgro
alone or 2) Ralgro plus Finaplix-S. In this 77-day drylot growing trial, a 5.4% gain
response was obtained with Finaplix plus Ralgro as compared to Ralgro alone. In
general, effects of Finaplix on cattle performance were inconsistent across trials.
However, implanting cattle with Finaplix and either Ralgro or Synovex tended to
result in increased gain, final weight, and carcass weight, with little effect on backfat
thickness, ribeye area or percentage kidney, heart, and pelvic fat observed, when
compared to cattle receiving only estrogenic implants. Marbling score and the
percentage of cattle grading Choice tended to be reduced slightly, although this was
not usually significant.
Key words: Steers, Heifers, Anabolic Implant, Performance, Carcass.
